Explore the words cloud of the PRETREAT project. It provides you a very rough idea of what is the project "PRETREAT" about.
The following table provides information about the project.
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
|Coordinator Country||France [FR]|
|Total cost||387˙000 €|
|EC max contribution||387˙000 € (100%)|
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
|Duration (year-month-day)||from 2016-01-01 to 2019-12-31|
Take a look of project's partnership.
|1||INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE||FR (PARIS)||coordinator||94˙500.00|
|2||MOSAIQUES DIAGNOSTICS GMBH||DE (HANNOVER)||participant||148˙500.00|
|3||IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON||EL (ATHINA)||participant||90˙000.00|
|4||HYBRIDSTAT PREDICTIVE ANALYTICS OE||EL (ATHENS)||participant||54˙000.00|
|5||EMERGENTEC BIODEVELOPMENT GMBH||AT (VIENNA)||participant||0.00|
Cardiovascular disease (VD) is the leading cause of mortality and morbidity in Europe and worldwide. The objective of the PRETREAT consortium is to generate a joint SME/academic European preclinical platform for providing services for detection of VD and drug development. This platform will combine the use of urinary and/or blood peptidomics in humans and in preclinical animal models of VD, together with bioinformatics and systems biology, in order to better detect, stratify and decipher the molecular mechanisms of VD, develop new animal models with high similarity to human disease, and provide new tools for obtaining information on novel drug targets. PRETREAT builds on the FP7 project Sysvasc (systems biology to identify molecular targets for vascular disease treatment, 2014-2018) and the combined expertise of the PRETREAT partners in clinical proteomics, proteomics, animal models and system medicine as the pillars to implement this platform. The work will be carried out in an extensive exchange program totaling 27 secondments. Main objectives during the secondments include establishment of the link between urinary markers and the pathophysiology of VD, identification of additional animal VD models with similarity to human VD, development of “humanized” body fluid readouts in VD models, establishment of a VD protein-centric database in order to automatically link urinary peptides to in situ changes and provide information on drug targets, and provide proof-of-concept of the utility of the proposed platform. These secondments will in parallel serve to keep information flowing within the project, increase individual research efficiency and create a multi-disciplinary working chain, train personnel, and prepare the sustainability of the results after the project. To complete training, 3 monthly webinars and four workshops are planned.
|PRETREAT flyer||Websites, patent fillings, videos etc.||2019-05-31 17:27:28|
|PRETREAT public webpage ready||Websites, patent fillings, videos etc.||2019-05-31 17:27:27|
Take a look to the deliverables list in detail: detailed list of PRETREAT deliverables.
|year||authors and title||journal||last update|
Mercedes Arguello Casteleiro, Julie Klein, Robert Stevens
The Proteasix Ontology
published pages: , ISSN: 2041-1480, DOI: 10.1186/s13326-016-0078-9
|Journal of Biomedical Semantics 7/1||2019-06-17|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRETREAT" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PRETREAT" are provided by the European Opendata Portal: CORDIS opendata.